• 1
    Lepine L, Hillis S, Marchbanks P et al. Hysterectomy surveillance − United States 1980–93. MMWR 1997; 46 (SS-4): 115.
  • 2
    Carlson K, Nichols D, Schiff I. Current concepts: indications for hysterectomy. NEJM 1993; 328: 85660.
  • 3
    Lee NC, Dicker RC, Rubin GL, Ory HW. Confirmation of the preoperative diagnoses for hysterectomy. Am J Obstet Gynecol 1985; 152: 8038.
  • 4
    Wingo P, Huezo C, Rubin G, Ory H, Peterson H. The mortality risk associated with hysterectomy. Am J Obstet Gynecol 1985; 152: 8038.
  • 5
    Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 4859.
  • 6
    Edlund M, Blomback M, Von Schoultz B, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996; 53: 2348.
  • 7
    Dilley A, Drews C, Miller C et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obst Gynecol 2001; 97: 6306.
  • 8
    Feinman RD, Lubowsky J, Charo I, Zabinski MP. The lumi-aggregometer: a new instrument for simultaneous measurement of secretion and aggregation by platelets. J Lab Clin Med 1977; 90: 1259.
  • 9
    Machin SJ, Preston E. Guidelines on platelet function testing. J Clin Pathol 1988; 41: 132230.
  • 10
    Miller CH, Dilley A, Richardson L, Hooper WC, Evatt BL. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. Am J Hematol 2001; 67: 1259.
  • 11
    Higham JM, O'Brien PMS, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obst Gynecol 1990; 97: 7349.
  • 12
    Janssen CAH, Scholten PC, Heintz APM. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 1995; 85: 97782.
  • 13
    Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Eng J Med 1972; 287: 1559.
  • 14
    Duke WW. The relation of blood platelets to hemorrhagic disease: description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. JAMA 1910; 55: 118592.
  • 15
    Fernandez F, Goudable C, Sie P et al. Low hematocrit and prolonged bleeding time in uremic patients: effects of red blood cell transfusions. Br J Haematol 1985; 59: 13948.
  • 16
    Small M, Lowe GDO, Cameron E, Forbes CD. Contribution of the hematocrit to the bleeding time. Haemostasis 1983; 13: 37984.
  • 17
    Buchanan GR, Holtkamp CA, Levy EN. Racial differences in ristocetin-induced platelet aggregation. Br J Haematol 1981; 49: 45564.
  • 18
    Mackie I, Bull H, Kennedy J, Brozovic M. Ristocetin-induced platelet agglutination in Afro-Caribbean and Caucasian people. Br J Haematol 1982; 50: 1713.
  • 19
    Rao GH, White JG. Epinephrine and platelet function. J Lab Clin Med 1997; 130: 2389.
  • 20
    Scrutton MC, Clare KA, Hutton RA, Bruckdorfer KR. Depressed responsiveness to adrenaline in platelets from apparently normal human donors: a familial trait. Br J Haematol 1981; 49: 30314.
  • 21
    Kambayashi J, Shinoki N, Nakamura T et al. Prevalence of impaired responsiveness to epinephrine in platelets among Japanese. Thromb Res 1996; 81: 8590.
  • 22
    Tamponi G, Pannocchia A, Arduino C et al. Congenital deficiency of alpha-2-adrenoceptors on human platelets: description of two cases. Thromb Haemost 1987; 58: 10126.
  • 23
    Rao AK, Willis J, Kowalska MA, Wachtfogel YT, Colman RW. Differential requirements for platelet aggregation andinhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha2-adrenergic receptor defect. Blood 1988; 71: 494501.
  • 24
    Lalau Keraly C, Kinlough-Rathbone RL, Packham MA, Suzuki H, Mustard JF. Conditions affecting the responses of human platelets to epinephrine. Thromb Haemost 1988; 60: 20916.
  • 25
    Shattil SJ, Budzynski A, Scrutton MC. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists. Blood 1989; 73: 1508.
  • 26
    Blomback M, Eneroth P, Landgren BM, Lagerstrom M, Anderson O. On the Intraindividual and gender variability of hemostatic components. Thromb Haemost 1992; 67: 705.
  • 27
    Mandalaki T, Louizou C, Dimitriadou C, Symeonidis P. Variations in factor VIII during the menstrual cycle in normal women. NEJM 1980; 302: 1093.
  • 28
    Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptives. Thromb Haemost 1999; 82: 145661.
  • 29
    Kouides P, Phatak P, Sham RL et al. Adjusting the reference range of von Willebrand factor levels and factor VIIIc level in relation to the menstrual cycle [abstract]. Blood 1997; 90: 32a.
  • 30
    Miller CH, Dilley AB, Drews C, Richardson L, Evatt B. Changes in von Willebrand factor and factor VIII levels during the menstrual cycle. Thromb Haemost 2002; 87: 10823.
  • 31
    The MEDSTAT Group. MEDSTAT Data Base. The MEDSTAT Group, Ann Arbor, MI. Accessed 2000.
  • 32
    Rees M. Menorrhagia. BMJ 1987; 294: 75962.